but in the
80s, diagnosing hiv was like chasing a shadow in the dark. unlike the relatively straightforward hiv tests that exist today, those early years were marked by a diagnostic vacuum that left countless individuals in the dark about their hiv status, unwittingly allowing the virus to spread. it wasn’t until 1985 that the world began to get a glimpse of the silent epidemic, when the fda licensed the first
test to screen blood for exposure to hiv. this groundbreaking moment set the stage for a new era of scientific inquiry, laying the foundation for the effective testing methods and treatments that exist today.
the personal impact and response to hiv
yet, amidst this shifting landscape, tragedy struck when both rosenes and his partner at the time learned that they were hiv positive. despite their shared journey, rosenes’ partner succumbed to the virus. reflecting on this painful period, he shares that his partner’s passing compelled him to get involved in hiv advocacy.
“his death, along with the loss of several friends, including my first cousin, had a profound impact on me,” says rosenes.
during this period of turmoil and loss, organizations like the
aids committee of toronto became lifelines for those seeking information on how to navigate life with hiv. around the same time, scientists stumbled upon
azt, a drug they were originally investigating to treat cancer. it turned out to be the very first fda-approved medication for aids in 1987, and it was the spark that ignited the era of antiretroviral therapy. as time went on, more research and clinical trials paved the way for even better and less harsh drugs, laying the foundation for combination therapies that revolutionized hiv management. the pivotal moment arrived in mid-1990s with the introduction of
highly active antiretroviral therapy (haart), dramatically reducing mortality rates and enhancing the quality of life for people with hiv.